Amarin Corp Plcuk (AMRN) Inventory Average (2012 - 2026)
Amarin Corp Plc\Uk (AMRN) posted quarterly Inventory Average of $173.8 million for Q2 2026, up 5.13% year-over-year from $165.4 million in Q2 2025, and down 8.38% quarter-over-quarter from $189.8 million in Q1 2026.
Amarin Corp Plcuk (AMRN) Inventory Average (2012 - 2026) Analysis & Trends
Amarin Corp Plc\Uk (AMRN) has reported Inventory Average for 15 consecutive years, with $173.8 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Inventory Average rose 5.13% year-over-year to $173.8 million; the TTM figure through Jun 2026 stood at $173.8 million (up 5.13% YoY), while the FY2025 annual figure was $181.0 million, down 14.77% from the prior year.
- Inventory Average retreated to $173.8 million in Q2 2026 per AMRN's latest filing, from $189.8 million in the prior quarter.
- Across five years, Inventory Average topped out at $257.0 million in Q1 2024 and bottomed at $162.8 million in Q1 2025.
- Historically, Inventory Average has averaged $216.4 million across 5 years, with a median of $227.0 million in 2022.
- Annual changes were most pronounced in 2022 — Inventory Average increased 19.71% — and 2025, when it plunged 36.65%.
- Amarin Corp Plc\Uk's Inventory Average stood at $228.2 million in 2022, then grew by 12.44% to $256.6 million in 2023, then declined by 23.98% to $195.0 million in 2024, then dropped by 2.42% to $190.3 million in 2025, then dropped by 8.65% to $173.8 million in 2026.
- Business Quant data shows AMRN's Inventory Average at $173.8 million in Q2 2026, $189.8 million in Q1 2026, and $190.3 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.20 Bn | 631.44 Bn | 17.26 Bn | 14.86 Bn |
| 2 | AbbVie | 469.51 Bn | 462.94 Bn | 12.70 Bn | 5.09 Bn |
| 3 | Merck | 376.81 Bn | 369.67 Bn | 12.21 Bn | 6.34 Bn |
| 4 | Novartis Ag | 303.04 Bn | 295.35 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.61 Bn | 252.71 Bn | 12.86 Bn | 6.75 Bn |
| 6 | Amgen | 237.37 Bn | 223.38 Bn | 7.24 Bn | 6.20 Bn |
| 7 | Gilead Sciences | 181.73 Bn | 178.55 Bn | 6.22 Bn | 1.93 Bn |
| 8 | Pfizer | 159.66 Bn | 147.96 Bn | 10.94 Bn | 10.31 Bn |
| 9 | Gsk | 106.24 Bn | 102.07 Bn | 8.24 Bn | 8.36 Bn |
| 10 | Amarin Corp Plcuk | 5.86 Bn | 5.54 Bn | 14.99 Mn | 173.85 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 173.85 Mn |
| Mar 31, 2026 | 189.76 Mn |
| Dec 31, 2025 | 190.31 Mn |
| Sep 30, 2025 | 177.97 Mn |
| Jun 30, 2025 | 165.37 Mn |
| Mar 31, 2025 | 162.77 Mn |
| Dec 31, 2024 | 195.02 Mn |
| Sep 30, 2024 | 231.70 Mn |
| Jun 30, 2024 | 247.35 Mn |
| Mar 31, 2024 | 256.96 Mn |
| Dec 31, 2023 | 256.56 Mn |
| Sep 30, 2023 | 240.76 Mn |
| Jun 30, 2023 | 226.42 Mn |
| Mar 31, 2023 | 227.27 Mn |
| Dec 31, 2022 | 228.17 Mn |
| Sep 30, 2022 | 226.70 Mn |
| Jun 30, 2022 | 246.81 Mn |
| Mar 31, 2022 | 251.25 Mn |
| Dec 31, 2021 | 271.99 Mn |
| Sep 30, 2021 | 290.90 Mn |